Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: Implications for placental hemostasis

Thrombosis and Haemostasis

Volumn 92, Issue 4, 2004, Pages 776-786

  Aharon, Anat ^a   Brenner, Benjamin ^a   Katz, Tamar ^a   Miyagi, Yohei ^b   Lanir, Naomi ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

Inflammation; Placenta; Tissue factor; Tissue factor inhibitor (TFPI); Trophoblast

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; PROCOAGULANT; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLEEDING; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FETUS BLOOD; GENE EXPRESSION; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MATERNAL BLOOD; PLACENTA CIRCULATION; PLACENTA FUNCTION; PLACENTA VILLUS; PREGNANCY; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST; UMBILICAL VEIN; VASCULARIZATION;

CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; LIPOPROTEINS; PLACENTA; RNA, MESSENGER; THROMBOPLASTIN; TROPHOBLASTS; UMBILICAL VEINS;

EID: 6344244577     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-01-0033     Document Type: Article

References (49)

1. Brenner B, Blumenfeld Z. Thrombophilia and fetal loss. Blood Rev 1997; 11: 72-79.
2. Lanir N, Aharon A, Brenner B. Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Hemost 2003; 29: 175-84.
3. Kuczynski J, Uszynski W, Zekanowska E, et al. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium. Eur J Obstet Gynecol Reprod Biol 2002; 105: 15-19.
4. Lockwood C J, Krikun G, Runic R, et al. Progestin epidermal growth factor regulation of tissue factor expression during decudualization of human endometrial stromal cells. J Clin Endocrinol Metabol 2000; 85: 297-301.
5. Uszynski M, Zekanowska E, Uszynski W, et al. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 2001; 95: 163-6.
6. Chen J, Bierhaus A, Schiekofer S, et al. Tissue factor-a receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost 2001; 86: 334-45.
7. Parry GC, Mackman N. Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. J Clin Invest 2000; 105: 1547-54.
8. Carson SD, Ramsey CA. Tissue factor is present in placental microvilli and cofractionates with microvilli membrane proteins. Placenta 1985; 6:5-12
9. Reverdiau P, Jarousseau AC, Thibault G, et al. Tissue factor activity of syncythiotrohoblasts plasma membranes and tumoral trophoblasts cells in culture. Thromb Haemost 1995; 73: 49-54.
10. Faulk WP, Labarrere CA, Carson SD. Tissue factor: Identification and characterization of cell types in human placenta. Blood 1990; 76: 86-96.
11. Meszaros K, Aberle S, Dedrick R, et al. Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD 14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein. Blood 1994; 83: 2516-25.
12. Mattsson E, Herwald H, Bjorck L, et al. Peptidoglycan from staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytes. Infect. Immunol. 2002; 70: 3033-9.
13. Wada H, Wakita Y, Shiku H. Tissue factor expression in endothelial cells in health and disease. Blood Coagul Fibrinolysis 1995; 6: S26-31.
14. Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost 2001; 86: 959-72.
15. Bajaj MS, Kuppuswamy MN, Manepalli AN, et al. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues. Thromb Haemost 1999; 82: 1047-52.
16. Miyagi Y, Koshikawa N, Yasumitsu H, et al. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. J Biochem 1994; 116: 939-42.
17. Udagawa K, Miyagi Y, Hirahara F, et al. Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization. Placenta 1998; 19: 217-23.
18. Udagawa K, Yasumitsu H, Esaki M, et al. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts. Placenta 2002; 23: 145-53.
19. Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopta vascular phenotype as they differentiate A strategy for successful endovascular invasion? J Clin Invest 1997; 99:2139-51
20. Edstrom CS, Calhoun DA, Christensen RD. Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Hum Dev 2000; 59: 77-84.
21. Fazel A, Vincenot A, Malassine A, et al. Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli. Placenta 1998; 19: 261-8.
22. Isermann B, Sood R, Pawlinski R, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med 2003; 9: 331-7.
23. Kliman HJ, Nestler J, Sermasi E, et al. Purification, characterization and in vitro differentiation of cytotrophoblassts from human term placentae. Endocrinology 1986; 118: 1567-81.
24. Jaffe EA, Nachman RL, Becher GG, et al. Culture of endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-56.
25. Sandset PM, Larsen ML, Abildgaard U, Lindahl AK, Qdegaard OR. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): Levels In normal population and relation to cholesterol. Blood Coagul Fibrinolysis 1991; 2: 425-33.
26. Iochmann S, Reverdiau MP, Beaujean S, et al. Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction. Thromb Res 1999; 94: 165-73.
27. Nemerson Y. Tissue factor and haemostasis. Blood 1998; 71: 1-8.
28. Potgens AJ, Schmitz U, Bose P, et al. Mechanisms of syncytial fusion. Placenta 2002; 23: S107-S113.
29. Hubé F, Reverdiau P, Iochmann S, et al. Demonstration of a tissue factor pathway inhibitor 2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas. Biol Reprod 2003; 68: 1888-94.
30. Potgens AJ, Kataoka H, Ferstl S, et al. A positive immunoselection method to isolate villous cytotrophoblast cells from first trimester and term placenta to high purity. Placenta 2003; 24: 412-23.
31. Malassine A, Cronier L. Hormones and human trophoblast differentiation: a review. Endocrine 2002; 19: 3-11.
32. Rand JH, Wu XX. Guller S et al. Antiphosphlipid immunoglobulin G antibodies reduce annexin V levels in syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obst Gynecol 1997; 177: 918-23.
33. Aasrum M, Prydz H. Gene targeting of tissue factor, factor X and factor VII in mice, their involvement in embryonic development. Biochemistry (Mosc). 2002; 67: 25-32.
34. Lockwood C J, Krikun G, Schatz F. The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol 1999; 17: 45-51.
35. Nemerson Y, Giesen PL. Some thoughts about localization and expression of tissue factor. Blood Coagul Fibrinolysis 1998; 9: S45-47
36. Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000; 10: 139-43.
37. Chand HS, Schmidt AE, Bajaj SP, et al Structure function analysis of the reactive site in the first kunitz-type domain of human tissue factor pathway inhibitor-2. J Biol Chem 2004; 79:17500-7.
38. Herman HP, Sukhova KG, Kisiel W, et al. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 2001; 107: 1117-26.
39. Ruf W, Seftor AE, Petrovan JR, et al. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res 2003; 63: 5381-9.
40. Konduri SD, Tasiou A, Chandrasekar N, et al. Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion. Clin Exp Metastasis 2000; 18: 303-8.
41. Bowen JM, Chamley L, Mitchell MD, et al. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002; 23: 239-56.
42. Baergen R, Benirschke K, Ulich TR. Cytokine expression in the placenta. The role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and parturition. Arch Pathol Lab Med 1994; 118: 52-5.
43. Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol 1995; 15: 612-21.
44. Rounioja S, Rasanen J, Glumoff V, et al. Intra-amniotic lipopolysaccharide leads to fetal cardiac dysfunction. A mouse model for fetal inflammatory response. Cardiovasc Res 2003; 60: 156-64.
45. Kohmura Y, Kirikae T, Kirikae F, et al. Lipopolysaccharide (LPS)-induced intra-uterine fetal death (IUFD) in mice is principally due to maternal cause but not fetal sensitivity to LPS. Microbiol Immunol 2000; 44: 897-904.
46. Estelles A, Gilabert J, Grancha S, et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 1998; 79: 500-8.
47. Ameri A, Kuppuswamy MN, Basu S, et al. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood 1992; 79: 3219-26.
48. Speiser W, Kapiotis S, Kopp CW, et al. Effect of intradermal tumor necrosis factor- induced inflammation on coagulation factors in dermal vessel endothelium. Thromb Haemost 2001; 85: 362-7.
49. Kereveur A. Enjyoji K, Masuda K, et al. Production of tissue factor pathway inhibitor in cardiomyocytes and its upregulation by interleukin-1. Thromb Haemost 2001; 86: 1314-9.